Teshima Romane, Sakuragi Yumiko, Saito-Sasaki Natsuko, Okada Etsuko, Sawada Yu
Dermatology, Hospital of University of Occupational and Environmental Health, Kitakyushu, JPN.
Dermatology, Hospital of University of Occupational and Environmental Health, Kitakyusyu, JPN.
Cureus. 2023 Nov 26;15(11):e49453. doi: 10.7759/cureus.49453. eCollection 2023 Nov.
Langerhans cell histiocytosis (LCH) is a clonal proliferative disease of immature Langerhans cells that expand in various organs, leading to organ and tissue dysfunction. Although LCH is most commonly seen in children under the age of three, a small number of cases of congenital LCH have been described. With a review of the literature on congenital LCH with lung and skin lesions, we present a case of congenital LCH with involvement of skin and lung, which was effectively treated with chemotherapy without recurrence for 3 years during the observational period. In addition, we summarized previously published case studies of congenital LCH with skin and lung involvement.
朗格汉斯细胞组织细胞增多症(LCH)是一种未成熟朗格汉斯细胞的克隆性增殖性疾病,这些细胞在各个器官中扩张,导致器官和组织功能障碍。虽然LCH最常见于三岁以下儿童,但也有少数先天性LCH病例的报道。通过回顾有关伴有肺和皮肤病变的先天性LCH的文献,我们报告了一例累及皮肤和肺的先天性LCH病例,该病例在观察期内接受化疗后有效治疗,3年未复发。此外,我们总结了先前发表的伴有皮肤和肺受累的先天性LCH的病例研究。